Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109790114B details high-purity Maraviroc intermediate synthesis using nickel chelates for improved yield and supply chain reliability in pharmaceutical manufacturing.
Novel chiral synthesis of Rasagiline Mesylate from 1-indanone. High yield, low cost, industrial scale-up ready for Parkinson's API intermediates.
Patent CN112979701A details a novel nickel-catalyzed resolution for L-glufosinate-ammonium. Achieve >95% yield and ee value with significant cost reduction in agrochemical manufacturing.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.
Novel asymmetric acetal method for (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one synthesis. High ee%, low cost, scalable process for API manufacturing.
Patent CN114014787B details a high-purity asymmetric route for florfenicol intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel synthetic route for HCV NS5A inhibitor intermediate offering cost reduction and scalable manufacturing for pharmaceutical supply chains globally.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Patent CN117105887A reveals a novel Salen Co-catalyzed resolution for chiral epichlorohydrin. Achieve high purity, catalyst recycling, and significant cost reduction in pharmaceutical manufacturing.
Novel enzymatic route for Sacubitril intermediates offers cost reduction in API manufacturing. High-purity cardiovascular drug synthesis suitable for commercial scale-up.
Patent CN112552184B reveals a scalable 4-step synthesis for cyclopropyl chiral amines, offering significant cost reduction and high purity for pharmaceutical manufacturing.
Patent CN101270112A details a polymeric Schiff base-metal complex for high-ee cyclic carbonates, offering superior recyclability and cost efficiency for pharma intermediates.
Patent CN112538033A details a Pd-catalyzed kinetic resolution method yielding high-purity chiral cyclophanes with superior enantioselectivity and scalability.
Novel patent CN121342695A offers scalable chiral amino acid synthesis. Reduces waste and cost for IL-17 inhibitor intermediates. Reliable supply chain partner.
Patent CN106008316B enables cost-effective Ledipasvir intermediate production. Discover scalable synthesis routes for high-purity pharmaceutical intermediates supply.
Patent CN101935309A reveals a novel Ezetimibe synthesis using indeno-oxazole auxiliaries, offering 99.97% ee and scalable manufacturing for reliable API intermediate supply chains.
Patent CN109761984B details a novel ruthenium-catalyzed asymmetric hydrogen transfer method for synthesizing chiral purine nucleosides with high enantioselectivity and mild conditions.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN114315609A discloses a novel 3-step process for cis-2-aminocyclohexanol from cyclohexene, offering significant cost reduction and scalability for pharmaceutical manufacturing.